Ampio Pharmaceuticals
AMPE
#10613
Rank
โ‚ฌ0 M
Marketcap
0,004466ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Ampio Pharmaceuticals (AMPE)

Revenue in 2023 (TTM): N/A

a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ampio Pharmaceuticals from 2009 to 2023

Annual revenue

Year Revenue Change
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A-100%
2015 โ‚ฌ0.42 M579.69%
2014 โ‚ฌ0.06 M74.38%
2013 โ‚ฌ0.03 M-4.22%
2012 โ‚ฌ0.03 M161.8%
2011 โ‚ฌ0.01 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Aerie Pharmaceuticals
AERI
โ‚ฌ0.18 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ86.23 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
โ‚ฌ0.24 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ37.65 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ12.23 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA